Fibrin/Fibrinogen Degradation Split Products, Plasma
Also known as: FDP PLASMA
Use
This test measures the levels of fibrin degradation products in plasma, which can be indicative of rare disorders such as primary fibrinolysis. It is not the preferred test for evaluating coagulopathies like disseminated intravascular coagulation, where D-Dimer testing is recommended.
Special Instructions
Patient preparation includes collection of the sample in a light blue (sodium citrate) tube. It is crucial to refer to ARUP's specimen handling guidelines for hemostasis/thrombosis tests.
Limitations
The test cannot be used for serum, EDTA plasma, clotted, or hemolyzed specimens, which are deemed unacceptable. It is also important that the plasma is platelet-poor and transported critically frozen to maintain stability.
New York Approved
Methodology
Immunoassay (Latex Agglutination)
Biomarkers
LOINC Codes
- 30226-5
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube
Collection Instructions
Collect sample in a light blue (sodium citrate) tube and transfer platelet-poor plasma to the transport tube.
Patient Preparation
Refer to hemostasis/thrombosis specimen handling guidelines.
Storage Instructions
Transport critically frozen. Separate specimens must be submitted when multiple tests are ordered.
Causes for Rejection
Serum, EDTA plasma, clotted or hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 8 hours |
| Refrigerated | Unacceptable |
| Frozen | 3 months |